Plasma Protien Extraction
I find that yesterdays NR was an excellent "on track" report. That is verified by the three investment houses that have came out with a positive interpratation.
Can some one please clarify for me, are the PBI 4050 and plasminogen products the result of their advances in protien extraction?
If so does this have any impact on the valuation of the extraction part of the company. Most of the investment houses say their valuation is a sum of the parts. Will a succesful Ph lll add value to that part of the business?
Fis On